发明名称 Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
摘要 The present invention concerns methods and compositions for making and using bioactive assemblies of defined compositions, which may have multiple functionalities and/or binding specificities. In particular embodiments, the bioactive assembly is formed using dock-and-lock (DNL) methodology, which takes advantage of the specific binding interaction between dimerization and docking domains (DDD) and anchoring domains (AD) to form the assembly. In various embodiments, one or more effectors may be attached to a DDD or AD sequence. Complementary AD or DDD sequences may be attached to an adaptor module that forms the core of the bioactive assembly, allowing formation of the assembly through the specific DDD/AD binding interactions. Such assemblies may be attached to a wide variety of effector moieties for treatment, detection and/or diagnosis of a disease, pathogen infection or other medical or veterinary condition.
申请公布号 US2015010982(A1) 申请公布日期 2015.01.08
申请号 US201414488921 申请日期 2014.09.17
申请人 IBC PHARMACEUTICALS, INC. 发明人 Chang Chien-Hsing;Goldenberg David M.;McBride William J.;Rossi Edmund A.
分类号 C12N9/12;C07K14/475;C07K16/30;C07K16/28 主分类号 C12N9/12
代理机构 代理人
主权项 1. A fusion protein comprising: a) a dimerization and docking domain (DDD) moiety, wherein the amino acid sequence of the DDD moiety is selected from the group consisting of residues 1-44 of human protein kinase A (PKA) RIIα, residues 1-44 of human PKA RIIβ and residues 12-61 of human PKA RIα; and b) an effector protein selected from the group consisting of a cytokine, a toxin, an antibody and an antigen-binding antibody fragment.
地址 Morris Plains NJ US